Gene · 554210
Papers2,894
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,894
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. | Nat Med | 2026 | 42749887 | PubTator, text mining | PubMed |
| MicroRNA Expression Profiles Before and After Neoadjuvant Chemotherapy in Breast Cancer: Correlations with Molecular Subtypes, Pathological Response, and Clinical Timing-A Pilot Translational Study. | Int J Mol Sci | 2026 | 42737706 | PubTator, text mining | PubMed |
| [Molecular Mechanism of microRNA-429 Targeting HMOX1 to Regulate Invasion, Migration, and Ferroptosis in Lung Adenocarcinoma Cells]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | 42688334 | PubTator, text mining | PubMed |
| Clinicopathological and Prognostic Implications of Circulating MicroRNA-429 in Breast Cancer Patients. | Ann Afr Med | 2026 | 42594098 | PubTator, text mining | PubMed |
| Long non-coding RNA SNHG6 promotes the proliferation of PASMCs cells through the miR-429/DUSP1 axis during early/subacute vascular responses to pulmonary embolism. | Mol Cell Biochem | 2026 | 42550429 | PubTator, text mining | PubMed |
| ZNF662 inhibits oncogenesis through NUPR1/p53 signaling pathway in epithelial ovarian cancer and is regulated by hsa-miR-429. | Cell Mol Biol Lett | 2026 | 42243650 | PubTator, text mining | PubMed |
| Fe3O4 Magnetic Nanoparticles and Static Magnetic Field Stimulated BMSC-Derived Exosomes Promoted Osteogenesis and Alleviated Oxidative Stress in Irradiated BMSCs Through miR-429/NOG Pathway. | Bioengineering (Basel) | 2026 | 42072196 | PubTator, text mining | PubMed |
| The role of MicroRNAs in modulating ZEB2-driven EMT and metastasis. | Surg Oncol | 2026 | 41980500 | PubTator, text mining | PubMed |
| Urinary Exosomal miRNAs as Non-Invasive Biomarkers Linked to Podocyte Morphometry in CKD. | Cells | 2026 | 41972684 | PubTator, text mining | PubMed |
| Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response. | Cancer Immunol Immunother | 2026 | 41925746 | PubTator, text mining | PubMed |
| Emerging miRNA biomarkers in breast cancer: The role of miR-223, miR-326, and miR-429 in tumor profiling. | Mol Biol Rep | 2026 | 41920379 | PubTator, text mining | PubMed |
| MicroRNA Regulation in Kidney Interstitial Fibrosis. | Epigenomes | 2026 | 41892370 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| Tumor Suppressor p53 and MicroRNAs Interaction in Breast Cancer. | Oncol Res | 2026 | 41799525 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance. | Int J Mol Sci | 2026 | 41752055 | PubTator, text mining | PubMed |
| Molecular Characterization of Muscle-Invasive Bladder Cancer: Key MicroRNAs, Transcription Factors, and Differentially Expressed Genes. | Genes (Basel) | 2026 | 41751506 | PubTator, text mining | PubMed |
| Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression. | Biomolecules | 2026 | 41750312 | PubTator, text mining | PubMed |
| miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification Approach. | Cancers (Basel) | 2026 | 41749839 | PubTator, text mining | PubMed |
| DUSP1: Triple-Negative Breast Cancer and Therapeutic Potential. | Curr Oncol | 2026 | 41744846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554210/papers